Skip to main content
. 2014 Jul 14;20(26):8709–8716. doi: 10.3748/wjg.v20.i26.8709

Figure 2.

Figure 2

Irritable bowel syndrome related quality of life score improvement compared to baseline after 42 d of treatment. A: Global scores improved significantly more in both treatment groups than placebo (Kruskall-Wallis test); B: Among the different domains, the mental status showed a significant improvement when compared to placebo.